Mulpleta 3 mg/1
Lusutrombopag · TABLET, FILM COATED · VANCOCIN ITALIA SRL
Mulpleta (lusutrombopag) is an oral tablet used to treat low blood platelet counts in patients with chronic liver disease who need to undergo a procedure. It works by stimulating the bone marrow to produce more platelets.
Key Facts
- Brand Name
- Mulpleta
- Generic Name
- Lusutrombopag
- NDC Code (Product)
84230-551- Manufacturer
- VANCOCIN ITALIA SRL
- Strength
- 3 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA210923
- Marketing Start
- 12/09/2025
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
Frequently Asked Questions
What is Mulpleta used for?
Mulpleta (lusutrombopag) is an oral tablet used to treat low blood platelet counts in patients with chronic liver disease who need to undergo a procedure. It works by stimulating the bone marrow to produce more platelets.
Is Mulpleta a controlled substance?
Mulpleta is not classified as a controlled substance by the DEA.
What is the generic name for Mulpleta?
The generic name for Mulpleta is Lusutrombopag. There are no other listed brand versions of Lusutrombopag.
What is the NDC code for Mulpleta 3 mg/1?
The NDC (National Drug Code) for Mulpleta 3 mg/1 is 84230-551, listed by VANCOCIN ITALIA SRL.
Other Mulpleta Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)